Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Contents

From AIDS Vaccine Advocacy Coalition

December 1996

Five Steps to a Vaccine for HIV

Executive Summary
 
Recommendations
A. Five Key Recommendations
B. Additional Recommendations
C. Key Principles

Introduction

I. Survey Background

A. Related Efforts on HIV Vaccines
B. Relevant Publications
C. Survey Methodology
D. Companies/Research Institution Interviewed
 
II. Survey Results -- Obstacles and Impediments
Highlighted Comments
A. Obstacles/Impediments Faced by Each Company
B. Specific Obstacles/Impediments
1. Liability concerns
2. Perception of limited consumer market
3. Demands for subsidized pricing
4. Opportunity costs
5. Scientific feasibility at this time
C. Ranking Specific Obstacles/Impediments
 
III. Survey Results -- What Industry Wants from Government
Highlighted Comments
A. A Question of Leadership
B. What Government Should Do
C. Specific Actions
1. Tax deductions or credits for investment
2. Expedited review by the FDA
3. Creating uniform international standards for licensing
4. Expanded patent protection
5. Guaranteed purchases by government
6. International coordination of vaccine research and distribution
7. Direct contracting between for specific research
8. Greater clarity about thresholds for phase II and III trials
9. Increased assistance in securing animal models
10. Changes in vaccine trial networks
D. Pros and Cons of Working With Government Agencies
E. Ranking Specific Actions Government Should Take
F. Government Leadership
 
IV. Corporations with HIV Vaccine Programs
 
Table of HIV Vaccine Effort by Company

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by AIDS Vaccine Advocacy Coalition. It is a part of the publication Industry Investment in HIV Vaccine Research.
 
 

Advertisement